Skip to main content
BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ: BCRX · Real-Time Price · USD
8.62
+0.14 (1.65%)
At close: Mar 9, 2026, 4:00 PM EDT
8.59
-0.03 (-0.35%)
After-hours: Mar 9, 2026, 7:17 PM EDT

BioCryst Pharmaceuticals Revenue

In the year 2025, BioCryst Pharmaceuticals had annual revenue of $874.84M with 94.10% growth. BioCryst Pharmaceuticals had revenue of $406.56M in the quarter ending December 31, 2025, with 209.09% growth.

Revenue (ttm)
$874.84M
Revenue Growth
+94.10%
P/S Ratio
2.47
Revenue / Employee
$2,011,120
Employees
435
Market Cap
2.16B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025874.84M424.13M94.10%
Dec 31, 2024450.71M119.30M36.00%
Dec 31, 2023331.41M60.59M22.37%
Dec 31, 2022270.83M113.66M72.31%
Dec 31, 2021157.17M139.36M782.38%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Bausch Health Companies 10.27B
Perrigo Company 4.25B
Phibro Animal Health 1.46B
Prestige Consumer Healthcare 1.10B
ANI Pharmaceuticals 883.37M
Supernus Pharmaceuticals 718.95M
Kiniksa Pharmaceuticals International, 677.56M
HUTCHMED (China) 548.51M
Revenue Rankings

BCRX News

More News